Position in CRDF
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$82,812
-$33,138 QoQ
Shares Held
51,119
+23.9% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,555,077,811 across 347 Biotechnology names. CRDF ranks #328 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in CRDF
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,812 | 51,119 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $115,950 | 41,264 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $101,600 | 49,321 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $294,187 | 93,393 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $101,368 | 32,283 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $147,611 | 34,012 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $121,121 | 45,364 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $119,630 | 53,888 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $345,631 | 64,725 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $73,686 | 49,788 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $69,205 | 49,788 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $73,188 | 49,788 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $131,864 | 79,918 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $45,669 | 32,621 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $115,296 | 74,869 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $219,636 | 99,835 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $40,833 | 16,465 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $264,251 | 43,969 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $301,516 | 45,273 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $200,767 | 30,191 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $5,557,923 | 600,208 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $23,134 | 1,286 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $714,451 | 50,349 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $350 | 70 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||